BR112019003890A2 - uso de oligossacarídeos de leite humano em engordamento de bezerros - Google Patents
uso de oligossacarídeos de leite humano em engordamento de bezerrosInfo
- Publication number
- BR112019003890A2 BR112019003890A2 BR112019003890-6A BR112019003890A BR112019003890A2 BR 112019003890 A2 BR112019003890 A2 BR 112019003890A2 BR 112019003890 A BR112019003890 A BR 112019003890A BR 112019003890 A2 BR112019003890 A2 BR 112019003890A2
- Authority
- BR
- Brazil
- Prior art keywords
- human milk
- milk oligosaccharides
- present
- oligosaccharides
- calves
- Prior art date
Links
- 210000004251 human milk Anatomy 0.000 title abstract 5
- 235000020256 human milk Nutrition 0.000 title abstract 5
- 229920001542 oligosaccharide Polymers 0.000 title abstract 5
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 5
- 244000309466 calf Species 0.000 title abstract 3
- 229940062827 2'-fucosyllactose Drugs 0.000 abstract 1
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 abstract 1
- HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical group O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 206010017964 Gastrointestinal infection Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dairy Products (AREA)
Abstract
a presente invenção refere-se ao uso de oligossacarídeos de leite humano para a alimentação de animais de produção, tais como bezerros. a presente invenção ulteriormente refere-se a composições substitutas de leite contendo oligossacarídeos de leite humano. outra matéria objeto da presente invenção é um método para a prevenção e tratamento de doenças gastrointestinais, particularmente infecções gastrointestinais, de animais de produção jovens, em particular bezerros, por administração de uma quantidade eficaz de um ou mais oligossacarídeos de leite humano. particularmente útil no contexto da presente invenção como um ou o oligossacarídeo de leite humano é a 2'-fucosil-lactose (2-fl).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16186533.2 | 2016-08-31 | ||
| EP16186533 | 2016-08-31 | ||
| PCT/EP2017/071606 WO2018041803A1 (en) | 2016-08-31 | 2017-08-29 | Use of human milk oligosaccharides in calves fattening |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019003890A2 true BR112019003890A2 (pt) | 2019-05-21 |
Family
ID=56852129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019003890-6A BR112019003890A2 (pt) | 2016-08-31 | 2017-08-29 | uso de oligossacarídeos de leite humano em engordamento de bezerros |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190183145A1 (pt) |
| EP (1) | EP3506768A1 (pt) |
| JP (2) | JP2019528088A (pt) |
| KR (2) | KR20190045228A (pt) |
| CN (1) | CN109788781A (pt) |
| AU (2) | AU2017318386A1 (pt) |
| BR (1) | BR112019003890A2 (pt) |
| CA (1) | CA3035290A1 (pt) |
| MX (1) | MX2019002386A (pt) |
| WO (1) | WO2018041803A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220226382A1 (en) * | 2019-06-05 | 2022-07-21 | Morinaga Milk Industry Co., Ltd. | Nutritional Composition |
| WO2020246583A1 (ja) * | 2019-06-05 | 2020-12-10 | 森永乳業株式会社 | 組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020019991A1 (en) * | 1998-04-30 | 2002-02-14 | Abbott Laboratories | Compositions containing an alpha 1,2-fucose linkage and uses thereof |
| US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
| CN102257128A (zh) | 2008-12-19 | 2011-11-23 | 詹内怀恩生物技术股份有限公司 | 岩藻糖化化合物的合成 |
| NZ596099A (en) * | 2009-04-13 | 2013-11-29 | Childrens Hosp Medical Center | Milk oligosaccharide compositions and use thereof in treating infection in animals |
| CA2824960A1 (en) * | 2011-02-04 | 2012-08-09 | The Regents Of The University Of California | Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease |
| CA2827313C (en) * | 2011-02-16 | 2023-08-22 | Glycosyn LLC | Biosynthesis of human milk oligosaccharides in engineered bacteria |
| WO2012158517A1 (en) | 2011-05-13 | 2012-11-22 | Glycosyn LLC | The use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics |
| NL2007931C2 (en) * | 2011-12-07 | 2013-06-10 | Friesland Brands Bv | Methods for providing sialylated oligosaccharides and products obtainable thereby. |
| AU2014350156A1 (en) * | 2013-11-15 | 2016-04-14 | Nestec S.A. | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section |
| KR20170052631A (ko) * | 2014-09-12 | 2017-05-12 | 바스프 에스이 | 2＇-o-푸코실락토오스의 제조 방법 |
| SG11201811227QA (en) * | 2016-07-01 | 2019-01-30 | Evolve Biosystems Inc | Method for facilitating maturation of the mammalian immune system |
-
2017
- 2017-08-29 KR KR1020197008232A patent/KR20190045228A/ko not_active Application Discontinuation
- 2017-08-29 US US16/328,850 patent/US20190183145A1/en not_active Abandoned
- 2017-08-29 KR KR1020247002832A patent/KR20240016454A/ko not_active Application Discontinuation
- 2017-08-29 JP JP2019532188A patent/JP2019528088A/ja active Pending
- 2017-08-29 CA CA3035290A patent/CA3035290A1/en active Pending
- 2017-08-29 WO PCT/EP2017/071606 patent/WO2018041803A1/en active Application Filing
- 2017-08-29 EP EP17755546.3A patent/EP3506768A1/en active Pending
- 2017-08-29 AU AU2017318386A patent/AU2017318386A1/en not_active Abandoned
- 2017-08-29 BR BR112019003890-6A patent/BR112019003890A2/pt not_active Application Discontinuation
- 2017-08-29 CN CN201780052697.9A patent/CN109788781A/zh active Pending
- 2017-08-29 MX MX2019002386A patent/MX2019002386A/es unknown
-
2020
- 2020-12-22 US US17/130,195 patent/US20210212342A1/en active Pending
-
2022
- 2022-06-27 AU AU2022204538A patent/AU2022204538A1/en active Pending
-
2023
- 2023-06-07 JP JP2023093630A patent/JP2023123516A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3506768A1 (en) | 2019-07-10 |
| CN109788781A (zh) | 2019-05-21 |
| KR20190045228A (ko) | 2019-05-02 |
| WO2018041803A1 (en) | 2018-03-08 |
| US20190183145A1 (en) | 2019-06-20 |
| US20210212342A1 (en) | 2021-07-15 |
| MX2019002386A (es) | 2019-06-20 |
| KR20240016454A (ko) | 2024-02-06 |
| JP2019528088A (ja) | 2019-10-10 |
| JP2023123516A (ja) | 2023-09-05 |
| AU2017318386A1 (en) | 2019-03-21 |
| AU2022204538A1 (en) | 2022-07-21 |
| CA3035290A1 (en) | 2018-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015026882A2 (pt) | ração animal incluindo aditivo colesterol catiônico | |
| MX2021000085A (es) | Composiciones para animales, y sus usos. | |
| PH12016502323A1 (en) | Combination, composition, and method of administering the combination or composition to animals | |
| BR112018074927A2 (pt) | uso de indazóis substituídos para tratamento e prevenção de doenças alérgicas e/ou inflamatórias em animais | |
| BR112013027609A2 (pt) | bactérias bacillus para uso no tratamento e prevenção de infecção em animais aquáticos | |
| BR112015028692A8 (pt) | agente preventivo ou terapêutico para mastite de animal ruminante | |
| BR112017017599A2 (pt) | métodos para modular respostas imunológicas e inflamatórias pela administração de uma biomassa algal | |
| BR112012010689B8 (pt) | mistura antifúngica com organismo fúngico | |
| PH12019502241A1 (en) | Berberine alkaloids in the prevention and/or treatments of intestinal disease | |
| BR112019003890A2 (pt) | uso de oligossacarídeos de leite humano em engordamento de bezerros | |
| BRPI0800744A2 (pt) | composiÇço de inibiÇço de infecÇço por salmonella para pinto e mÉtodo de inibiÇço de infecÇço por salmonella em pintos | |
| GB2550750A (en) | Anthelmintic compounds | |
| MX2018011539A (es) | Tratamiento de dolencias y enfermedades cutaneas asociadas a biopeliculas microbianas. | |
| WO2016159583A3 (ko) | 지구자 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물 | |
| WO2016159584A3 (ko) | 상지 또는 상백피 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물 | |
| BR112016007057A2 (pt) | um método veterinário para induzir êmese | |
| MX2020010243A (es) | Composiciones bucales y metodos para animales. | |
| JP2016513738A5 (pt) | ||
| Ghulam Jilany et al. | Ciprofloxacin; the frequent use in poultry and its consequences on human health | |
| Tablante | Common Poultry Diseases and Their Prevention | |
| Du Pisanie | Scabby mouth: dangerous for man and animal | |
| Rasmussen et al. | Evaluation of Calcium Hydroxide (Ca (OH) 2) Used in Footbaths as Treatment and Prevention of Digital Dermatitis in Danish Dairy Cattle | |
| Ozaraga et al. | Ethnobotanical Anthelmintics for Free Range Native Chickens | |
| AU2011101109A4 (en) | Lubisan | |
| Ba et al. | Effects of a water spraying system on lying and excreting behaviours of fattening pigs in heat stress |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B154 | Notification of filing of divisional application [chapter 15.50 patent gazette] |
Free format text: O PEDIDO FOI DIVIDIDO NO BR122023000025-0 PROTOCOLO 870230000188 EM 02/01/2023 15:21. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |